Ethical issues in funding orphan drug research and development

This essay outlines the moral dilemma of funding orphan drug research and development. To date, ethical aspects of priority setting for research funding have not been an issue of discussion in the bioethics debate. Conflicting moral obligations of beneficence and distributive justice appear to deman...

Full description

Saved in:  
Bibliographic Details
Authors: Gericke, C. A. (Author) ; Riesberg, A. (Author) ; Busse, R. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2005
In: Journal of medical ethics
Year: 2005, Volume: 31, Issue: 3, Pages: 164-168
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002 4500
001 1816128171
003 DE-627
005 20220908053409.0
007 cr uuu---uuuuu
008 220908s2005 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme.2003.007138  |2 doi 
035 |a (DE-627)1816128171 
035 |a (DE-599)KXP1816128171 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Gericke, C. A.  |e VerfasserIn  |4 aut 
245 1 0 |a Ethical issues in funding orphan drug research and development 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a This essay outlines the moral dilemma of funding orphan drug research and development. To date, ethical aspects of priority setting for research funding have not been an issue of discussion in the bioethics debate. Conflicting moral obligations of beneficence and distributive justice appear to demand very different levels of funding for orphan drug research. The two types of orphan disease, rare diseases and tropical diseases, however, present very different ethical challenges to questions about allocation of research funds. The dilemma is analysed considering utilitarian and rights based theories of justice and moral obligations of non-abandonment and a professional obligation to advance medical science. The limitations of standard economic evaluation tools and other priority setting tools used to inform health policy decision makers on research funding decisions are outlined. 
700 1 |a Riesberg, A.  |e VerfasserIn  |4 aut 
700 1 |a Busse, R.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 31(2005), 3, Seite 164-168  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:31  |g year:2005  |g number:3  |g pages:164-168 
856 |3 Volltext  |u http://www.jstor.org/stable/27719361  |x JSTOR 
856 |u https://jme.bmj.com/content/medethics/31/3/164.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via free pdf)] 
856 4 0 |u https://doi.org/10.1136/jme.2003.007138  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/31/3/164.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
936 u w |d 31  |j 2005  |e 3  |h 164-168 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185582021 
LOK |0 003 DE-627 
LOK |0 004 1816128171 
LOK |0 005 20220908053409 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#34350B94E7C9F2E0C0D606F7F77E185EAD3C0015 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/27719361 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw